moponetug (BMS-986446) - BMS
Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants. (clinicaltrials.gov) - Oct 2, 2026 - P1 | N=10 | Not yet recruiting | Sponsor: Bristol-Myers Squibb 
New P1 trial
http://clinicaltrials.gov/ct2/show/NCT07852962
 
Oct 2, 2026
 
Prev Next